Chinook Therapeutics Inc (KDNY) - Financial and Strategic SWOT Analysis Review


Chinook Therapeutics, Inc (Chinook)., formerly Aduro BioTech Inc is a clinical-stage immunotherapy company that discovers, develops and commercializes therapies for the treatment of cancer. The company develops product candidates using proprietary technology platforms such as live, attenuated, double-deleted listeria, sting pathway activators; and B-select monoclonal antibodies to create immunotherapies for the treatment of cancers, infectious and autoimmune diseases. Its products are under development and are intended for the treatment of variety of cancers, including metastatic colorectal, multiple myeloma cancers, as well as other solid tumors and lymphomas. The company collaborates with various pharmaceutical companies to expand its products and technology platforms. It has an operational presence in The Netherlands. Chinook is headquartered in Berkeley, California, the US.

Chinook Therapeutics Inc Key Recent Developments

Sep 20,2021: Chinook Therapeutics to Present at Upcoming Investor Conferences
Aug 12,2021: Chinook Therapeutics Provides Business Update and Reports Second Quarter 2021 Financial Results
Jun 09,2021: Chinook Therapeutics Announces Promotions of Tom Frohlich to Chief Operating Officer and Andrew King, D.V.M, Ph.D., to Chief Scientific Officer
May 13,2021: Chinook Therapeutics to Present at the 2021 RBC Capital Markets Global Healthcare Conference
May 12,2021: Chinook Therapeutics Provides Business Update and Reports First Quarter 2021 Financial Results

This comprehensive SWOT profile of Chinook Therapeutics Inc provides you an in-depth strategic analysis of the companys businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalDatas Profile on Demand service, covering over 50,000 of the worlds leading companies. Once purchased, GlobalDatas highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Chinook Therapeutics Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description A detailed description of the companys operations and business divisions.
- Corporate strategy Analysts summarization of the companys business strategy.
- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
- Company history Progression of key events associated with the company.
- Major products and services A list of major products, services and brands of the company.
- Key competitors A list of key competitors to the company.
- Key employees A list of the key executives of the company.
- Executive biographies A brief summary of the executives employment history.
- Key operational heads A list of personnel heading key departments/functions.
- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The companys core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Table of Contents

Section 1 - About the Company

Chinook Therapeutics Inc - Key Information
Chinook Therapeutics Inc - Overview
Chinook Therapeutics Inc - Key Employees
Chinook Therapeutics Inc - Key Employee Biographies
Chinook Therapeutics Inc - Key Operational Heads
Chinook Therapeutics Inc - Major Products and Services
Chinook Therapeutics Inc - History
Chinook Therapeutics Inc - Company Statement
Chinook Therapeutics Inc - Locations And Subsidiaries
Chinook Therapeutics Inc
Head Office
Other Locations & Subsidiaries

Section 2 - Company Analysis

Chinook Therapeutics Inc - Business Description
Chinook Therapeutics Inc - Corporate Strategy
Chinook Therapeutics Inc - SWOT Analysis
SWOT Analysis - Overview
Chinook Therapeutics Inc - Strengths
Chinook Therapeutics Inc - Weaknesses
Chinook Therapeutics Inc - Opportunities
Chinook Therapeutics Inc - Threats
Chinook Therapeutics Inc - Key Competitors

Section 3 - Company Financial Performance Charts

Chinook Therapeutics Inc - Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

Section 4 - Appendix

Ratio Definitions
About GlobalData
Contact Us

Note*: Some sections may be missing if data is unavailable for the company

List Of Tables

List of Tables

Chinook Therapeutics Inc, Key Information
Chinook Therapeutics Inc, Key Ratios
Chinook Therapeutics Inc, Share Data
Chinook Therapeutics Inc, Major Products and Services
Chinook Therapeutics Inc, History
Chinook Therapeutics Inc, Key Employees
Chinook Therapeutics Inc, Key Employee Biographies
Chinook Therapeutics Inc, Key Operational Heads
Chinook Therapeutics Inc, Other Locations
Chinook Therapeutics Inc, Subsidiaries
Chinook Therapeutics Inc, Key Competitors
Chinook Therapeutics Inc, SWOT Analysis
Chinook Therapeutics Inc, Ratios based on current share price
Chinook Therapeutics Inc, Annual Ratios
Chinook Therapeutics Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

List of Figures

Chinook Therapeutics Inc, Performance Chart
Chinook Therapeutics Inc, Ratio Charts

Anika Therapeutics Inc (ANIK) - Product Pipeline Analysis, 2021 Update

Anika Therapeutics Inc (Anika) develops, manufactures, and markets therapeutic products for degenerative orthopedic diseases and traumatic conditions. It offers solutions for ortho-biologics, dermal, ophthalmic, surgical and veterinary applications. Its major

USD 750 View Report

Panbela Therapeutics Inc (PBLA) - Financial and Strategic SWOT Analysis Review

Panbela Therapeutics Inc (Panbela), formerly Sun BioPharma Inc is a biopharmaceutical company. It develops disruptive therapeutics for treatment of pancreatic cancer and pancreatitis. The companys pipeline products include SBP-101. Its

USD 300 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available